Advertisement
Screener

HeartSciences Inc. (HSCS) Overview

HeartSciences Inc. (HSCS) Overview

  • 1 Aug 2025: Period ending 31 Oct 2025; Estimate (m); Actual -0.85; Beat / miss (m).
  • 1 May 2025: Period ending 31 Jul 2025; Estimate (m); Actual -1.58; Beat / miss (m).
  • 1 Nov 2024: Period ending 31 Jan 2025; Estimate (m); Actual -2.57; Beat / miss (m).
  • 1 Aug 2024: Period ending 31 Oct 2024; Estimate (m); Actual -2.27; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$1.59$2.03$2.59$3.32$4.24$5.432025-11-062026-11-06$1.59$2.07$2.70$3.53$4.60$6.012025-05-122026-11-06$1.59$2.07$2.70$3.53$4.60$6.012025-05-122026-11-06$1.59$2.07$2.70$3.53$4.60$6.012025-05-122026-11-06$1.59$2.07$2.70$3.53$4.60$6.012025-05-122026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$2.77
Previous close
$4.74
Change
-$1.97
Change (%)
-41.61%
Close date
2026-11-06
Previous close date
2026-09-24
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · (m)

YTD

HSCS
(m)
S&P 500
(m)

1 year

HSCS
(m)
S&P 500
(m)

3 years

HSCS
(m)
S&P 500
(m)

5 years

HSCS
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

31 Oct 2025 ○ Estimate (m) ● Actual -0.85

-2.72-2.21-1.70-1.18-0.6731 Jul 2024: estimate (m); actual -2.6431 Jul 2024(m)31 Oct 2024: estimate (m); actual -2.2731 Oct 2024(m)31 Jan 2025: estimate (m); actual -2.5731 Jan 2025(m)31 Jul 2025: estimate (m); actual -1.5831 Jul 2025(m)31 Oct 2025: estimate (m); actual -0.8531 Oct 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Aug 202531 Oct 2025(m)-0.85(m)(m)
1 May 202531 Jul 2025(m)-1.58(m)(m)
1 Nov 202431 Jan 2025(m)-2.57(m)(m)
1 Aug 202431 Oct 2024(m)-2.27(m)(m)
1 May 202431 Jul 2024(m)-2.64(m)(m)

30 Apr 2025 ○ Estimate (m) ● Actual -9.34

-80.08-60.38-40.67-20.97-1.2730 Apr 2022: estimate (m); actual -1.4530 Apr 2022(m)30 Apr 2023: estimate (m); actual -80.0030 Apr 2023(m)30 Apr 2024: estimate (m); actual -18.7430 Apr 2024(m)30 Apr 2025: estimate (m); actual -9.3430 Apr 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 May 202430 Apr 2025(m)-9.34(m)(m)
1 May 202330 Apr 2024(m)-18.74(m)(m)
1 May 202230 Apr 2023(m)-80.00(m)(m)
1 May 202130 Apr 2022(m)-1.45(m)(m)

Revenue vs. Earnings

USD

31 Jul 2026 ■ Revenue 0.00M ■ Earnings -3.17M — Profit margin -151064.00%

-3.55M-151065.0%-2.24M-133102.8%-0.93M-115140.6%0.38M-97178.4%31 Oct 2025: revenue 0.00M; earnings -2.35M; profit margin -97179.37%31 Oct 202531 Jan 2026: revenue 0.00M; earnings -1.99M; profit margin (m)31 Jan 202630 Apr 2026: revenue 0.00M*; earnings -2.75M*; profit margin (m); Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2026-02-01 to 2026-04-30; USD.30 Apr 202631 Jul 2026: revenue 0.00M; earnings -3.17M; profit margin -151064.00%31 Jul 2026

30 Apr 2026 ■ Revenue 0.00M ■ Earnings -9.14M — Profit margin -211666.47%

-10.24M-211667.5%-6.45M-152948.6%-2.67M-94229.7%1.12M-35510.9%30 Apr 2023: revenue 0.01M; earnings -6.35M; profit margin -123384.27%30 Apr 202330 Apr 2024: revenue 0.02M; earnings -6.61M; profit margin -35511.87%30 Apr 202430 Apr 2025: revenue 0.00M; earnings -8.77M; profit margin -201499.52%30 Apr 202530 Apr 2026: revenue 0.00M; earnings -9.14M; profit margin -211666.47%30 Apr 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$2.77(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$2.77High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning HSCS

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 31 Jul 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-10.26M
Profit margin
-227024.23%
Return on assets · 12 month
-201.67%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
156.79K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
(m)
Total return · month
(m)
Total return · quarter
(m)
Total return · half year
(m)
Total return · year to date
(m)
Total return · 1 year
(m)
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$4.52K
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

HeartSciences Inc. Overview

View more →

(m)

(m)

SEC CIK
1468492
Industry (SIC)
6199 Finance Services
Country of operation
United States
Business address
550 RESERVE ST, SUITE 360, SOUTHLAKE, Texas, 76092, United States
Fiscal year end
0430
Phone
682-237-7781

Similar stocks

Stock NameCountryMarket CapPE Ratio
DarkHorse Technologies Inc. (ANY)$0.025B
Binah Capital Group, Inc. (BCG)United States$0.020B6.21
Pineapple Financial Inc. (PAPL)Canada$0.026B
AIxCrypto Holdings, Inc. (AIXC)United States$0.029B-1.02
AtlasClear Holdings, Inc. (ATCH)United States$0.030B
MDB Capital Holdings, LLC (MDBH)United States$0.016B
Fold Holdings, Inc. (FLD)United States$0.030B
VerifyMe, Inc. (VRME)United States$0.015B-1.55
House of Doge Inc. (HODO)United States$0.015B
TAO Synergies Inc. (TAOX)United States$0.033B